GlassScriptPhysician profile
Aabha Divya
NPI 1720868649
$10,726.94
in general payments reported to CMS, 2019-2025
14 companies · $6,482 in 2025
The $6,482 reported for 2025 was more than what 85% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,245 · 2025: $6,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,620 · Food and Beverage: $3,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,620.42 |
| Food and Beverage | $3,106.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,715.90 | 2024-2025 | Impella |
| Bolton Medical INC | $1,817.46 | 2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Edwards Lifesciences Corporation | $1,814.56 | 2024 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Abbott Laboratories | $1,477.21 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Atricure, INC. | $1,230.22 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic, INC. | $1,184.68 | 2024 | Corevalve Evolut R |
| Shockwave Medical, INC | $145.97 | 2025 | |
| Baxter Healthcare | $144.30 | 2025 | |
| Artivion, INC. | $81.72 | 2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Convatec INC. | $28.60 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $28.43 | 2025 | Uptravi |
| Davol INC. | $26.62 | 2025 | Progel Applicator Spray Tips |
| Merck Sharp & Dohme LLC | $17.23 | 2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.04 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aabha Divya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.